Glycogen synthase kinase-3beta inhibitors prevent cellular polyglutamine toxicity caused by the Huntington's disease mutation.

Source:http://linkedlifedata.com/resource/pubmed/id/12097329

J. Biol. Chem. 2002 Sep 13 277 37 33791-8

Download in:

View as

General Info

PMID
12097329